New Vernon Capital Holdings Ii LLC Harmony Biosciences Holdings, Inc. Transaction History
New Vernon Capital Holdings Ii LLC
- $186 Million
- Q3 2024
A detailed history of New Vernon Capital Holdings Ii LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, New Vernon Capital Holdings Ii LLC holds 14,716 shares of HRMY stock, worth $488,865. This represents 0.32% of its overall portfolio holdings.
Number of Shares
14,716
Previous 14,716
-0.0%
Holding current value
$488,865
Previous $443,000
32.51%
% of portfolio
0.32%
Previous 0.24%
Shares
2 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$373 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$194 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$115 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$86.6 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$64.1 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.97B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...